[HTML][HTML] Molecular mechanisms of α-synuclein neurodegeneration

EA Waxman, BI Giasson - Biochimica et Biophysica Acta (BBA)-Molecular …, 2009 - Elsevier
EA Waxman, BI Giasson
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2009Elsevier
α-Synuclein is an abundant highly charged protein that is normally predominantly localized
around synaptic vesicles in presynaptic terminals. Although the function of this protein is still
ill-defined, genetic studies have demonstrated that point mutations or genetic alteration
(duplications or triplications) that increase the number of copies of the α-synuclein (SCNA)
gene can cause Parkinson's disease or the related disorder dementia with Lewy bodies. α-
Synuclein can aberrantly polymerize into fibrils with typical amyloid properties, and these …
α-Synuclein is an abundant highly charged protein that is normally predominantly localized around synaptic vesicles in presynaptic terminals. Although the function of this protein is still ill-defined, genetic studies have demonstrated that point mutations or genetic alteration (duplications or triplications) that increase the number of copies of the α-synuclein (SCNA) gene can cause Parkinson's disease or the related disorder dementia with Lewy bodies. α-Synuclein can aberrantly polymerize into fibrils with typical amyloid properties, and these fibrils are the major component of many types of pathological inclusions, including Lewy bodies, which are associated with neurodegenerative diseases, such as Parkinson's disease. Genetic studies have clearly established that alteration in the α-synuclein gene can lead to neuronal demise. Although there is substantial evidence supporting the toxic nature of α-synuclein inclusions, other modes of toxicity such as oligomers have been proposed. In this review, some of the evidence for the different mechanisms of α-synuclein toxicity is presented and discussed.
Elsevier